The latest study on Radiopharmaceuticals in Nuclear Medicine Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Radiopharmaceuticals in Nuclear Medicine Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Radiopharmaceuticals in Nuclear Medicine and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
GE Healthcare (Subsidiary Of General Electric Company)
Taiyo Nippon Sanso Corporation
Institute Of Radioelement (IRE)
Fujifilm Holdings Corporation
Siemens Healthcare (Subsidiary Of Siemens AG)
Institute of Isotopes Co., Ltd.
Eczacibasi-Monrol
Ntp Radioisotopes (Pty), Ltd.
Institute of Atomic Energy Polatom Radioisotope Centre
Covidien, Plc
Nordion, Inc.
Board of Radiation And Isotope Technology (BRIT)
Cardinal Health, Inc.
Lantheus Medical Imaging, Inc.
Australian Nuclear Association And Technology Organization (ANSTO)
Cambridge Isotope Laboratories, Inc.
Isotec, Inc. (Sigma-Aldrich)
Rotem Industries, Ltd., Inc.
Bracco Imaging S.P.A.
IBA Group
Urenco Limited
Radiopharmaceuticals in Nuclear Medicine Market Analysis By Type Segment:
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
Radiopharmaceuticals in Nuclear Medicine Market Analysis By Application Segment:
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Other
The Radiopharmaceuticals in Nuclear Medicine Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Radiopharmaceuticals in Nuclear Medicine Report:
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Radiopharmaceuticals in Nuclear Medicine Market:
Radiopharmaceuticals in Nuclear Medicine market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
Detailed information about Key Top Competitors in the Global Radiopharmaceuticals in Nuclear Medicine Market
What is the expected Market size and growth rate of the Radiopharmaceuticals in Nuclear Medicine market for the forecast period
Where is the largest and fastest growing market for Radiopharmaceuticals in Nuclear Medicine market
How does the market relate to the overall economy, demography and other similar markets
What forces will shape the market going forward
Can I include additional segmentation / market segmentation
Radiopharmaceuticals in Nuclear Medicine market global report answers all these questions and many more.
The study objectives are:
To analyze and research the Radiopharmaceuticals in Nuclear Medicine Market status and future forecast.
To present the key Radiopharmaceuticals in Nuclear Medicine Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Frequently Asked Questions - FAQ:
How big is the opportunity for the Radiopharmaceuticals in Nuclear Medicine market
Which are the recent industry development that can be implemented to generate additional revenue streams
Who are the major players operating in the Radiopharmaceuticals in Nuclear Medicine market Which companies are the front runners
What are the major end-use industries of Radiopharmaceuticals in Nuclear Medicine market
Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Type (2019-2025)
1.3.2 Diagnostic Radiopharmaceuticals
1.3.3 Therapy Radiopharmaceuticals
1.3.4 Enriched Stable Isotopes
1.4 Market Segment by Application
1.4.1 Global Radiopharmaceuticals in Nuclear Medicine Market Share by Application (2019-2025)
1.4.2 Diagnostic Application
1.4.3 Therapeutic Application
1.4.4 Research
1.4.5 Pharmaceutical
1.4.6 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Radiopharmaceuticals in Nuclear Medicine Production Value 2014-2025
2.1.2 Global Radiopharmaceuticals in Nuclear Medicine Production 2014-2025
2.1.3 Global Radiopharmaceuticals in Nuclear Medicine Capacity 2014-2025
2.1.4 Global Radiopharmaceuticals in Nuclear Medicine Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2019-2025
2.2.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size CAGR of Key Regions
2.2.2 Global Radiopharmaceuticals in Nuclear Medicine Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Radiopharmaceuticals in Nuclear Medicine Capacity by Manufacturers
3.1.2 Global Radiopharmaceuticals in Nuclear Medicine Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturers (2014-2019)
3.2.2 Radiopharmaceuticals in Nuclear Medicine Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Radiopharmaceuticals in Nuclear Medicine Market Concentration Ratio (CR5 and HHI)
3.3 Radiopharmaceuticals in Nuclear Medicine Price by Manufacturers
3.4 Key Manufacturers Radiopharmaceuticals in Nuclear Medicine Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Radiopharmaceuticals in Nuclear Medicine Market
3.6 Key Manufacturers Radiopharmaceuticals in Nuclear Medicine Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Diagnostic Radiopharmaceuticals Production and Production Value (2014-2019)
4.1.2 Therapy Radiopharmaceuticals Production and Production Value (2014-2019)
4.1.3 Enriched Stable Isotopes Production and Production Value (2014-2019)
4.2 Global Radiopharmaceuticals in Nuclear Medicine Production Market Share by Type
4.3 Global Radiopharmaceuticals in Nuclear Medicine Production Value Market Share by Type
4.4 Radiopharmaceuticals in Nuclear Medicine Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Radiopharmaceuticals in Nuclear Medicine Consumption by Application
6 Production by Regions
6.1 Global Radiopharmaceuticals in Nuclear Medicine Production (History Data) by Regions 2014-2019
6.2 Global Radiopharmaceuticals in Nuclear Medicine Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Radiopharmaceuticals in Nuclear Medicine Production Growth Rate 2014-2019
6.3.2 United States Radiopharmaceuticals in Nuclear Medicine Production Value Growth Rate 2014-2019
6.3.3 Key Players in United States
6.3.4 United States Radiopharmaceuticals in Nuclear Medicine Import & Export
6.4 European Union
6.4.1 European Union Radiopharmaceuticals in Nuclear Medicine Production Growth Rate 2014-2019
6.4.2 European Union Radiopharmaceuticals in Nuclear Medicine Production Value Growth Rate 2014-2019
6.4.3 Key Players in European Union
6.4.4 European Union Radiopharmaceuticals in Nuclear Medicine Import & Export
6.5 China
6.5.1 China Radiopharmaceuticals in Nuclear Medicine Production Growth Rate 2014-2019
6.5.2 China Radiopharmaceuticals in Nuclear Medicine Production Value Growth Rate 2014-2019
6.5.3 Key Players in China
6.5.4 China Radiopharmaceuticals in Nuclear Medicine Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia
7 Radiopharmaceuticals in Nuclear Medicine Consumption by Regions
7.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption (History Data) by Regions
7.2 United States
7.2.1 United States Radiopharmaceuticals in Nuclear Medicine Consumption by Type
7.2.2 United States Radiopharmaceuticals in Nuclear Medicine Consumption by Application
7.3 European Union
7.3.1 European Union Radiopharmaceuticals in Nuclear Medicine Consumption by Type
7.3.2 European Union Radiopharmaceuticals in Nuclear Medicine Consumption by Application
7.4 China
7.4.1 China Radiopharmaceuticals in Nuclear Medicine Consumption by Type
7.4.2 China Radiopharmaceuticals in Nuclear Medicine Consumption by Application
7.5 Rest of World
7.5.1 Rest of World Radiopharmaceuticals in Nuclear Medicine Consumption by Type
7.5.2 Rest of World Radiopharmaceuticals in Nuclear Medicine Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia
8 Company Profiles
8.1 Bracco Imaging S.P.A.
8.1.1 Bracco Imaging S.P.A. Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Radiopharmaceuticals in Nuclear Medicine
8.1.4 Radiopharmaceuticals in Nuclear Medicine Product Introduction
8.1.5 Bracco Imaging S.P.A. Recent Development
8.2 Cambridge Isotope Laboratories, Inc.
8.2.1 Cambridge Isotope Laboratories, Inc. Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Radiopharmaceuticals in Nuclear Medicine
8.2.4 Radiopharmaceuticals in Nuclear Medicine Product Introduction
8.2.5 Cambridge Isotope Laboratories, Inc. Recent Development
8.3 Cardinal Health, Inc.
8.3.1 Cardinal Health, Inc. Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Radiopharmaceuticals in Nuclear Medicine
8.3.4 Radiopharmaceuticals in Nuclear Medicine Product Introduction
8.3.5 Cardinal Health, Inc. Recent Development
8.4 Covidien, Plc
8.4.1 Covidien, Plc Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Radiopharmaceuticals in Nuclear Medicine
8.4.4 Radiopharmaceuticals in Nuclear Medicine Product Introduction
8.4.5 Covidien, Plc Recent Development
8.5 Eczacibasi-Monrol
8.5.1 Eczacibasi-Monrol Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Radiopharmaceuticals in Nuclear Medicine
8.5.4 Radiopharmaceuticals in Nuclear Medicine Product Introduction
8.5.5 Eczacibasi-Monrol Recent Development
8.6 Fujifilm Holdings Corporation
8.6.1 Fujifilm Holdings Corporation Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Radiopharmaceuticals in Nuclear Medicine
8.6.4 Radiopharmaceuticals in Nuclear Medicine Product Introduction
8.6.5 Fujifilm Holdings Corporation Recent Development
8.7 GE Healthcare (Subsidiary Of General Electric Company)
8.7.1 GE Healthcare (Subsidiary Of General Electric Company) Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Radiopharmaceuticals in Nuclear Medicine
8.7.4 Radiopharmaceuticals in Nuclear Medicine Product Introduction
8.7.5 GE Healthcare (Subsidiary Of General Electric Company) Recent Development
8.8 IBA Group
8.8.1 IBA Group Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Radiopharmaceuticals in Nuclear Medicine
8.8.4 Radiopharmaceuticals in Nuclear Medicine Product Introduction
8.8.5 IBA Group Recent Development
8.9 Isotec, Inc. (Sigma-Aldrich)
8.9.1 Isotec, Inc. (Sigma-Aldrich) Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Radiopharmaceuticals in Nuclear Medicine
8.9.4 Radiopharmaceuticals in Nuclear Medicine Product Introduction
8.9.5 Isotec, Inc. (Sigma-Aldrich) Recent Development
8.10 Lantheus Medical Imaging, Inc.
8.10.1 Lantheus Medical Imaging, Inc. Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Radiopharmaceuticals in Nuclear Medicine
8.10.4 Radiopharmaceuticals in Nuclear Medicine Product Introduction
8.10.5 Lantheus Medical Imaging, Inc. Recent Development
8.11 Nordion, Inc.
8.12 Ntp Radioisotopes (Pty), Ltd.
8.13 Siemens Healthcare (Subsidiary Of Siemens AG)
8.14 Taiyo Nippon Sanso Corporation
8.15 Urenco Limited
8.16 Rotem Industries, Ltd., Inc.
8.17 Australian Nuclear Association And Technology Organization (ANSTO)
8.18 Board of Radiation And Isotope Technology (BRIT)
8.19 Institute of Atomic Energy Polatom Radioisotope Centre
8.20 Institute of Isotopes Co., Ltd.
8.21 Institute Of Radioelement (IRE)
9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global Radiopharmaceuticals in Nuclear Medicine Capacity, Production Forecast 2019-2025
9.1.2 Global Radiopharmaceuticals in Nuclear Medicine Production Value Forecast 2019-2025
9.2 Market Forecast by Regions
9.2.1 Global Radiopharmaceuticals in Nuclear Medicine Production and Value Forecast by Regions 2019-2025
9.2.2 Global Radiopharmaceuticals in Nuclear Medicine Consumption Forecast by Regions 2019-2025
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global Radiopharmaceuticals in Nuclear Medicine Production Forecast by Type
9.7.2 Global Radiopharmaceuticals in Nuclear Medicine Production Value Forecast by Type
9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 Radiopharmaceuticals in Nuclear Medicine Sales Channels
10.2.2 Radiopharmaceuticals in Nuclear Medicine Distributors
10.3 Radiopharmaceuticals in Nuclear Medicine Customers
11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Disclaimer
List of Tables and Figures
List of Tables and Figures
Figure Radiopharmaceuticals in Nuclear Medicine Product Picture
Table Radiopharmaceuticals in Nuclear Medicine Key Market Segments
Table Major Manufacturers Radiopharmaceuticals in Nuclear Medicine Covered in This Report
Table Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Type 2020-2027 (K Units) & (Million US$)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Shar by Type 2016-2027
Figure Diagnostic Radiopharmaceuticals Figures
Table Major Manufacturers of Diagnostic Radiopharmaceuticals
Figure Therapy Radiopharmaceuticals Figures
Table Major Manufacturers of Therapy Radiopharmaceuticals
Figure Enriched Stable Isotopes Figures
Table Major Manufacturers of Enriched Stable Isotopes
Table Global Radiopharmaceuticals in Nuclear Medicine Market Share by Application 2020-2027 (K Units)
Figure Diagnostic Application Use Case
Figure Therapeutic Application Use Case
Figure Research Use Case
Figure Pharmaceutical Use Case
Figure Other Use Case
Figure Radiopharmaceuticals in Nuclear Medicine Report Years Considered
Figure Global Radiopharmaceuticals in Nuclear Medicine Production Value Growth Rate 2016-2027 (Million US$)
Figure Global Radiopharmaceuticals in Nuclear Medicine Production 2016-2027 (K Units)
Figure Global Radiopharmaceuticals in Nuclear Medicine Capacity 2016-2027 (K Units)
Table Key Manufacturers Radiopharmaceuticals in Nuclear Medicine Capacity (K Units)
Figure Global Radiopharmaceuticals in Nuclear Medicine Price 2016-2027 (USD/Unit)
Table Global Radiopharmaceuticals in Nuclear Medicine Market Size of Key Regions (Million USD) & (K Units)
Table Global Radiopharmaceuticals in Nuclear Medicine Growth Rate of Key Regions 2020-2027 (Million USD)
Table Global Radiopharmaceuticals in Nuclear Medicine Market Share for of Regions 2020-2027 (K Units)
Table Market Top Trends
Table Global Radiopharmaceuticals in Nuclear Medicine Capacity by Manufacturers (2016-2020) (K Units)
Table Global Radiopharmaceuticals in Nuclear Medicine Capacity Market Share by Manufacturers (2016-2020)
Table Global Radiopharmaceuticals in Nuclear Medicine Production by Manufacturers (2016-2020) (K Units)
Table Global Radiopharmaceuticals in Nuclear Medicine Production Share by Manufacturers (2016-2020)
Figure Global Radiopharmaceuticals in Nuclear Medicine Production Share by Manufacturers in 2020
Table Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturers (2016-2020) (Million USD)
Table Radiopharmaceuticals in Nuclear Medicine Revenue Share by Manufacturers (2016-2020)
Figure Radiopharmaceuticals in Nuclear Medicine Value Share by Manufacturers in 2020
Table Global Radiopharmaceuticals in Nuclear Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Radiopharmaceuticals in Nuclear Medicine Price by Manufacturers 2016-2020 (USD/Unit)
Table Key Manufacturers Radiopharmaceuticals in Nuclear Medicine Plants/Factories Distribution
Table Key Manufacturers Radiopharmaceuticals in Nuclear Medicine Area Served
Table Date of Key Manufacturers Enter into Radiopharmaceuticals in Nuclear Medicine Market
Table Key Manufacturers Radiopharmaceuticals in Nuclear Medicine Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Diagnostic Radiopharmaceuticals Production and Production Value (2016-2020) (K Units) & (Million US$)
Table Global Therapy Radiopharmaceuticals Production and Production Value (2016-2020) (K Units) & (Million US$)
Table Global Enriched Stable Isotopes Production and Production Value (2016-2020) (K Units) & (Million US$)
Table Global Radiopharmaceuticals in Nuclear Medicine Production by Type (2016-2020) (K Units)
Table Global Radiopharmaceuticals in Nuclear Medicine Production Share by Type (2016-2020)
Figure Global Radiopharmaceuticals in Nuclear Medicine Production Market Share by Type (2016-2020)
Figure Global Radiopharmaceuticals in Nuclear Medicine Production Market Share by Type in 2020
Table Global Radiopharmaceuticals in Nuclear Medicine Production Value by Type (2016-2020) (Million US$)
Table Global Radiopharmaceuticals in Nuclear Medicine Production Value Share by Type (2016-2020)
Figure Global Radiopharmaceuticals in Nuclear Medicine Production Value Market Share by Type (2016-2020)
Figure Global Radiopharmaceuticals in Nuclear Medicine Production Value Market Share by Type in 2020
Table Radiopharmaceuticals in Nuclear Medicine Ex-factory Price by Type 2016-2020 (USD/Unit)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption by Application (2016-2020) (K Units)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Share by Application (2016-2020)
Figure Global Consumption Radiopharmaceuticals in Nuclear Medicine Market Share by Application (2016-2020)
Table Global Radiopharmaceuticals in Nuclear Medicine Production by Regions 2016-2020 (K Units)
Table Global Radiopharmaceuticals in Nuclear Medicine Production Market Share by Regions 2016-2020
Figure Global Radiopharmaceuticals in Nuclear Medicine Production Market Share by Regions 2016-2020
Figure Global Radiopharmaceuticals in Nuclear Medicine Production Market Share by Regions in 2020
Table Global Radiopharmaceuticals in Nuclear Medicine Production Value by Regions 2016-2020 (Million USD)
Table Global Radiopharmaceuticals in Nuclear Medicine Production Value Market Share by Regions 2016-2020
Figure Global Radiopharmaceuticals in Nuclear Medicine Production Value Market Share by Regions 2016-2020
Figure Global Radiopharmaceuticals in Nuclear Medicine Production Value Market Share by Regions in 2020
Table United States Radiopharmaceuticals in Nuclear Medicine Production and Value 2016-2020 (K Units) & (Million USD)
Figure United States Radiopharmaceuticals in Nuclear Medicine Production Growth Rate 2016-2020 (K Units)
Figure United States Radiopharmaceuticals in Nuclear Medicine Production Value Growth Rate 2016-2020 (Million USD)
Table United States Radiopharmaceuticals in Nuclear Medicine Import & Export (K Units)
Table European Union Radiopharmaceuticals in Nuclear Medicine Production and Value 2016-2020 (K Units) & (Million USD)
Figure European Union Radiopharmaceuticals in Nuclear Medicine Production Growth Rate 2016-2020 (K Units)
Figure European Union Radiopharmaceuticals in Nuclear Medicine Production Value Growth Rate 2016-2020 (Million USD)
Table European Union Radiopharmaceuticals in Nuclear Medicine Import & Export (K Units)
Table China Radiopharmaceuticals in Nuclear Medicine Production and Value 2016-2020 (K Units) & (Million USD)
Figure China Radiopharmaceuticals in Nuclear Medicine Production Growth Rate 2016-2020 (K Units)
Figure China Radiopharmaceuticals in Nuclear Medicine Production Value Growth Rate 2016-2020 (Million USD)
Table China Radiopharmaceuticals in Nuclear Medicine Import & Export (K Units)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Production Growth Rate 2016-2020 (K Units)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Production Value Growth Rate 2016-2020 (Million USD)
Figure Korea Radiopharmaceuticals in Nuclear Medicine Production Growth Rate 2016-2020 (K Units)
Figure Korea Radiopharmaceuticals in Nuclear Medicine Production Value Growth Rate 2016-2020 (Million USD)
Figure India Radiopharmaceuticals in Nuclear Medicine Production Growth Rate 2016-2020 (K Units)
Figure India Radiopharmaceuticals in Nuclear Medicine Production Value Growth Rate 2016-2020 (Million USD)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Production Growth Rate 2016-2020 (K Units)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Production Value Growth Rate 2016-2020 (Million USD)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption by Regions 2016-2020 (K Units)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Regions 2016-2020
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Regions 2016-2020
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Regions in 2020
Figure United States Radiopharmaceuticals in Nuclear Medicine Consumption Growth Rate (2016-2020) (K Units)
Table United States Radiopharmaceuticals in Nuclear Medicine Consumption by Type (2016-2020) (K Units)
Figure United States Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Type in 2020
Table United States Radiopharmaceuticals in Nuclear Medicine Consumption by Application (2016-2020) (K Units)
Figure United States Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Application in 2020
Figure European Union Radiopharmaceuticals in Nuclear Medicine Consumption Growth Rate (2016-2020) (K Units)
Table European Union Radiopharmaceuticals in Nuclear Medicine Consumption by Type (2016-2020) (K Units)
Figure European Union Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Type in 2020
Table European Union Radiopharmaceuticals in Nuclear Medicine Consumption by Application (2016-2020) (K Units)
Figure European Union Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Application in 2020
Figure China Radiopharmaceuticals in Nuclear Medicine Consumption Growth Rate (2016-2020) (K Units)
Table China Radiopharmaceuticals in Nuclear Medicine Consumption by Type (2016-2020) (K Units)
Figure China Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Type in 2020
Table China Radiopharmaceuticals in Nuclear Medicine Consumption by Application (2016-2020) (K Units)
Figure China Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Application in 2020
Figure Rest of World Radiopharmaceuticals in Nuclear Medicine Consumption Growth Rate (2016-2020) (K Units)
Table Rest of World Radiopharmaceuticals in Nuclear Medicine Consumption by Type (2016-2020) (K Units)
Figure Rest of World Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Type in 2020
Table Rest of World Radiopharmaceuticals in Nuclear Medicine Consumption by Application (2016-2020) (K Units)
Figure Rest of World Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Application in 2020
Figure Japan Radiopharmaceuticals in Nuclear Medicine Consumption Growth Rate (2016-2020) (K Units)
Figure Korea Radiopharmaceuticals in Nuclear Medicine Consumption Growth Rate (2016-2020) (K Units)
Figure India Radiopharmaceuticals in Nuclear Medicine Consumption Growth Rate (2016-2020) (K Units)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Consumption Growth Rate (2016-2020) (K Units)
Table Bracco Imaging S.P.A. Company Details
Table Bracco Imaging S.P.A. Description and Business Overview
Table Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2020)
Table Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Production Growth Rate (2016-2020)
Table Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Production Market Share in Global Market
Table Bracco Imaging S.P.A. Recent Development
Table Cambridge Isotope Laboratories, Inc. Company Details
Table Cambridge Isotope Laboratories, Inc. Description and Business Overview
Table Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2020)
Table Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Production Growth Rate (2016-2020)
Table Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Production Market Share in Global Market
Table Cambridge Isotope Laboratories, Inc. Recent Development
Table Cardinal Health, Inc. Company Details
Table Cardinal Health, Inc. Description and Business Overview
Table Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2020)
Table Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Production Growth Rate (2016-2020)
Table Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Production Market Share in Global Market
Table Cardinal Health, Inc. Recent Development
Table Covidien, Plc Company Details
Table Covidien, Plc Description and Business Overview
Table Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2020)
Table Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Production Growth Rate (2016-2020)
Table Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Production Market Share in Global Market
Table Covidien, Plc Recent Development
Table Eczacibasi-Monrol Company Details
Table Eczacibasi-Monrol Description and Business Overview
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2020)
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Production Growth Rate (2016-2020)
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Production Market Share in Global Market
Table Eczacibasi-Monrol Recent Development
Table Fujifilm Holdings Corporation Company Details
Table Fujifilm Holdings Corporation Description and Business Overview
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2020)
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Production Growth Rate (2016-2020)
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Production Market Share in Global Market
Table Fujifilm Holdings Corporation Recent Development
Table GE Healthcare (Subsidiary Of General Electric Company) Company Details
Table GE Healthcare (Subsidiary Of General Electric Company) Description and Business Overview
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2020)
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Production Growth Rate (2016-2020)
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Production Market Share in Global Market
Table GE Healthcare (Subsidiary Of General Electric Company) Recent Development
Table IBA Group Company Details
Table IBA Group Description and Business Overview
Table IBA Group Radiopharmaceuticals in Nuclear Medicine Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2020)
Table IBA Group Radiopharmaceuticals in Nuclear Medicine Production Growth Rate (2016-2020)
Table IBA Group Radiopharmaceuticals in Nuclear Medicine Production Market Share in Global Market
Table IBA Group Recent Development
Table Isotec, Inc. (Sigma-Aldrich) Company Details
Table Isotec, Inc. (Sigma-Aldrich) Description and Business Overview
Table Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2020)
Table Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Production Growth Rate (2016-2020)
Table Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Production Market Share in Global Market
Table Isotec, Inc. (Sigma-Aldrich) Recent Development
Table Lantheus Medical Imaging, Inc. Company Details
Table Lantheus Medical Imaging, Inc. Description and Business Overview
Table Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2020)
Table Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Production Growth Rate (2016-2020)
Table Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Production Market Share in Global Market
Table Lantheus Medical Imaging, Inc. Recent Development
Table Nordion, Inc. Company Details
Table Ntp Radioisotopes (Pty), Ltd. Company Details
Table Siemens Healthcare (Subsidiary Of Siemens AG) Company Details
Table Taiyo Nippon Sanso Corporation Company Details
Table Urenco Limited Company Details
Table Rotem Industries, Ltd., Inc. Company Details
Table Australian Nuclear Association And Technology Organization (ANSTO) Company Details
Table Board of Radiation And Isotope Technology (BRIT) Company Details
Table Institute of Atomic Energy Polatom Radioisotope Centre Company Details
Table Institute of Isotopes Co., Ltd. Company Details
Table Institute Of Radioelement (IRE) Company Details
Table Global Radiopharmaceuticals in Nuclear Medicine Capacity, Production Forecast 2020-2027 (K Units)
Figure Global Radiopharmaceuticals in Nuclear Medicine Capacity Forecast 2020-2027 (K Units)
Figure Global Radiopharmaceuticals in Nuclear Medicine Production Forecast 2020-2027 (K Units)
Figure Global Radiopharmaceuticals in Nuclear Medicine Production Value Forecast 2020-2027 (Million US$)
Table Global Radiopharmaceuticals in Nuclear Medicine Production Value Forecast 2020-2027 (Million US$)
Table Global Radiopharmaceuticals in Nuclear Medicine Production Forecast by Regions 2020-2027 (K Units)
Table Global Radiopharmaceuticals in Nuclear Medicine Production Market Share Forecast by Regions 2020-2027
Table Global Radiopharmaceuticals in Nuclear Medicine Production Value Forecast by Regions 2020-2027 (Million US$)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Forecast by Regions 2020-2027 (K Units)
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Market Share Forecast by Regions 2020-2027
Table United States Radiopharmaceuticals in Nuclear Medicine Production and Production Value Forecast 2020-2027 (K Units) & (Million US$)
Figure United States Radiopharmaceuticals in Nuclear Medicine Production Growth Forecast 2020-2027 (K Units)
Table United States Radiopharmaceuticals in Nuclear Medicine Production Value Forecast 2020-2027 (Million US$)
Figure United States Radiopharmaceuticals in Nuclear Medicine Consumption Forecast 2020-2027 (K Units)
Table European Union Radiopharmaceuticals in Nuclear Medicine Production and Production Value Forecast 2020-2027 (K Units) & (Million US$)
Figure European Union Radiopharmaceuticals in Nuclear Medicine Production Growth Forecast 2020-2027 (K Units)
Table European Union Radiopharmaceuticals in Nuclear Medicine Production Value Forecast 2020-2027 (Million US$)
Figure European Union Radiopharmaceuticals in Nuclear Medicine Consumption Forecast 2020-2027 (K Units)
Table China Radiopharmaceuticals in Nuclear Medicine Production and Production Value Forecast 2020-2027 (K Units) & (Million US$)
Figure China Radiopharmaceuticals in Nuclear Medicine Production Growth Forecast 2020-2027 (K Units)
Table China Radiopharmaceuticals in Nuclear Medicine Production Value Forecast 2020-2027 (Million US$)
Figure China Radiopharmaceuticals in Nuclear Medicine Consumption Forecast 2020-2027 (K Units)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Production Growth Forecast 2020-2027 (K Units)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Consumption Forecast 2020-2027 (K Units)
Figure Korea Radiopharmaceuticals in Nuclear Medicine Production Growth Forecast 2020-2027 (K Units)
Figure Korea Radiopharmaceuticals in Nuclear Medicine Consumption Forecast 2020-2027 (K Units)
Figure India Radiopharmaceuticals in Nuclear Medicine Production Growth Forecast 2020-2027 (K Units)
Figure India Radiopharmaceuticals in Nuclear Medicine Consumption Forecast 2020-2027 (K Units)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Production Growth Forecast 2020-2027 (K Units)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Consumption Forecast 2020-2027 (K Units)
Table Global Radiopharmaceuticals in Nuclear Medicine Production Forecast by Type 2020-2027 (K Units)
Figure Global Radiopharmaceuticals in Nuclear Medicine Production Forecast by Type 2020-2027 (K Units)
Figure Global Radiopharmaceuticals in Nuclear Medicine Production Market Share Forecast by Type 2020-2027
Table Global Radiopharmaceuticals in Nuclear Medicine Production Value Forecast by Type 2020-2027 (Million US$)
Figure Global Radiopharmaceuticals in Nuclear Medicine Production Value Forecast by Type 2020-2027 (Million US$)
Figure Global Radiopharmaceuticals in Nuclear Medicine Production Value Market Share Forecast by Type 2020-2027
Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Forecast by Application 2020-2027 (K Units)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Forecast by Application 2020-2027 (K Units)
Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Market Share Forecast by Application 2020-2027
Figure Radiopharmaceuticals in Nuclear Medicine Value Chain
Table Radiopharmaceuticals in Nuclear Medicine Distributors List
Table Radiopharmaceuticals in Nuclear Medicine Customers List
Table Porter's Five Forces Analysis
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources